However, ZMYND8 could not rescue the proliferation inhibition caused by TROJAN knockdown in MCF7 cells, indicating that TROJAN did not participate in the ZMYND8-mediated pathway in ER+ breast cancer (Additional files 3: Fig. S3e). The gene discussed is ESR1; the disease is breast cancer.